. 2018 Jun 5;2018:7635274. doi: 10.1155/2018/7635274

Table 1.

Physiological parameters at 0, 2, and 4 weeks.

Week	Control			ANG II-salt
	Control			Vehicle			Benzbromarone			Olmesartan
	0	2	4	0	2	4	0	2	4	0	2	4
Body weight (g)	209 ± 13	348 ± 16	405 ± 41	205 ± 13	204 ± 33^∗	197 ± 42^∗	205 ± 12	239 ± 31^∗	224 ± 50^∗	208 ± 14	304 ± 14^∗^,#	363 ± 21^#
TP (g/dL)	5.7 ± 0.2	5.8 ± 0.1	6.0 ± 0.2	5.4 ± 0.2	5.7 ± 0.6	5.9 ± 0.5	5.4 ± 0.3	5.5 ± 0.6	6.1 ± 0.8	5.6 ± 0.1	6.0 ± 0.4	6.4 ± 0.4
UA (mg/dL)	0.48 ± 0.14	0.78 ± 0.34	0.68 ± 0.19	0.49 ± 0.22	0.63 ± 0.59	1.77 ± 1.22^∗	0.53 ± 0.27	0.89 ± 0.43	1.04 ± 0.29	0.40 ± 0.14	0.92 ± 0.44	0.56 ± 0.34^#
Cr (mg/dL)	0.54 ± 0.12	0.79 ± 0.17	0.45 ± 0.12	0.50 ± 0.23	0.74 ± 0.23	0.84 ± 0.48	0.61 ± 0.18	0.47 ± 0.35	0.95 ± 0.69	0.48 ± 0.07	0.87 ± 0.59	0.61 ± 0.37
BUN (mg/dL)	22.1 ± 10.9	16.5 ± 3.0	22.1 ± 3.4	22.6 ± 10.2	35.5 ± 10.2^∗	42.0 ± 33.8	20.4 ± 6.9	39.6 ± 6.3^∗	42.2 ± 21.1	18.1 ± 7.4	21.5 ± 4.8^#	24.5 ± 6.3
AST (IU/L)	28.8 ± 1.8	30.6 ± 4.9	28.8 ± 3.6	31.2 ± 3.8	29.5 ± 2.5	31.6 ± 10.2	30.9 ± 3.6	34.8 ± 12.1	42.0 ± 19.6	29.6 ± 4.0	32.9 ± 3.3	27.5 ± 2.2
ALT (IU/L)	7.5 ± 1.5	7.6 ± 1.0	8.2 ± 1.1	7.7 ± 0.9	9.7 ± 2.7	18.6 ± 5.6^∗	7.8 ± 1.1	11.1 ± 3.3	16.5 ± 7.2^∗	7.1 ± 1.4	9.3 ± 1.4	9.4 ± 2.1^#
U-pro (mg/day)	4 ± 2	8 ± 2	9 ± 2	4 ± 2	313 ± 170^∗	255 ± 278^∗	4 ± 3	255 ± 100^∗	255 ± 88^∗	5 ± 3	14 ± 8^#	18 ± 11^#

Values are expressed as the means ± SD (control, n = 5, others, n = 3–11). ^∗P < 0.05 compared with the control group, ^#P < 0.05 compared with the vehicle group at the same week.